Quantamental Technologies’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,451
Closed -$593K 421
2022
Q1
$593K Buy
+10,451
New +$560K 0.34% 103
2021
Q4
Sell
-7,140
Closed -$353K 395
2021
Q3
$353K Buy
+7,140
New +$387K 0.24% 152
2020
Q4
Sell
-10,182
Closed -$478K 123
2020
Q3
$478K Buy
10,182
+6,301
+162% +$323K 0.35% 85
2020
Q2
$203K Sell
3,881
-2,985
-43% -$154K 0.14% 247
2020
Q1
$329K Buy
+6,866
New +$356K 0.77% 46
2019
Q4
Sell
-1,084
Closed -$51K 550
2019
Q3
$51K Buy
+1,084
New +$49.5K 0.02% 964
2019
Q1
Sell
-14,897
Closed -$664K 1490
2018
Q4
$664K Buy
+14,897
New +$776K 0.4% 10

Other funds holding CAH

Quantamental Technologies's CAH Position: Q2 2022 in Review

Quantamental Technologies sold out of Cardinal Health (CAH) in Q2 2022, closing a stake of 10,451 shares — an estimated $593K sold.

Quantamental Technologies first reported a position in CAH in Q4 2018 and held it in 7 quarters. The position peaked at $664K in Q4 2018. 792 funds tracked by Wall St. Rank hold CAH as of Q2 2022.

  • Quantamental Technologies reported no remaining Cardinal Health position as of Q2 2022 after selling out during the quarter.
  • Quantamental Technologies sold 10,451 Cardinal Health shares in Q2 2022, an estimated $593K.
  • Quantamental Technologies first reported a position in Cardinal Health in Q4 2018 and held it in 7 quarters.
  • Quantamental Technologies's Cardinal Health position peaked at $664K in Q4 2018.
  • 792 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2022.

Based on Quantamental Technologies's 13F filing for Q2 2022, filed 15 Aug 2022.